Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City
Recruiting
Observational Study
ST Elevation Myocardial Infarction
Cardiogenic Shock
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 400 (estimated)
- Sponsor
- Abu Dhabi Health Services Company · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age more than 18.
* STEMI complicated by cardiogenic shock.
* Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
* Patient admitted between January 2019 to March 2024.
Exclusion Criteria:
* Age less than 18.
* Shock patient not related t…
Contacts